SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $17,329,000 | +4.8% | 1,604,543 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $16,534,000 | -21.0% | 1,613,065 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $20,935,000 | +1.3% | 1,602,979 | -14.7% | 0.00% | 0.0% |
| Q1 2016 | $20,661,000 | +7.0% | 1,878,240 | -10.5% | 0.00% | 0.0% |
| Q4 2015 | $19,318,000 | +29.5% | 2,099,759 | -2.3% | 0.00% | 0.0% |
| Q3 2015 | $14,914,000 | -32.8% | 2,148,952 | -4.9% | 0.00% | -25.0% |
| Q2 2015 | $22,181,000 | +21.2% | 2,258,803 | +9.4% | 0.00% | +33.3% |
| Q1 2015 | $18,295,000 | +1.9% | 2,064,884 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $17,946,000 | +19.7% | 2,048,593 | -5.8% | 0.00% | 0.0% |
| Q3 2014 | $14,990,000 | +24.1% | 2,175,669 | -5.3% | 0.00% | +50.0% |
| Q2 2014 | $12,079,000 | +1.9% | 2,296,344 | -11.8% | 0.00% | 0.0% |
| Q1 2014 | $11,853,000 | -20.8% | 2,604,989 | -12.3% | 0.00% | -33.3% |
| Q4 2013 | $14,967,000 | +9.9% | 2,969,701 | +10.5% | 0.00% | 0.0% |
| Q3 2013 | $13,620,000 | -4.2% | 2,686,413 | -6.2% | 0.00% | 0.0% |
| Q2 2013 | $14,211,000 | – | 2,865,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |